25 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
ASMB Assembly Biosciences, Inc. $34.41 $875.61M Downtrend
Article Searches
Orbimed Advisors Llc Buys Regeneron Pharmaceuticals Inc, Amicus Therapeutics Inc, Loxo Oncology ... http://www.gurufocus.com/news/658490/orbimed-advisors-llc-buys-regeneron-pharmaceuticals-inc-amicus-therapeutics-inc-loxo-oncology-inc-sells-incyte-corp-aetna-inc-biogen-inc Mar 29, 2018 - Orbimed Advisors Llc Buys Regeneron Pharmaceuticals Inc, Amicus Therapeutics Inc, Loxo Oncology Inc, Sells Incyte Corp, Aetna Inc, Biogen Inc, Stocks: REGN,LOXO,NVRO,ASMB,DCPH,EVHC,FOLD,RYTM,SCPH,DVA,A, release date:Mar 29, 2018
Orbimed Advisors Llc Buys Regeneron Pharmaceuticals Inc, Amicus Therapeutics Inc, Loxo Oncology ... http://www.gurufocus.com/news/652597/orbimed-advisors-llc-buys-regeneron-pharmaceuticals-inc-amicus-therapeutics-inc-loxo-oncology-inc-sells-incyte-corp-aetna-inc-biogen-inc Mar 14, 2018 - Orbimed Advisors Llc Buys Regeneron Pharmaceuticals Inc, Amicus Therapeutics Inc, Loxo Oncology Inc, Sells Incyte Corp, Aetna Inc, Biogen Inc, Stocks: REGN,LOXO,NVRO,ASMB,DCPH,EVHC,FOLD,RYTM,SCPH,DVA,A, release date:Mar 14, 2018
Orbimed Advisors Llc Buys Regeneron Pharmaceuticals Inc, Amicus Therapeutics Inc, Loxo Oncology ... http://www.gurufocus.com/news/651902/orbimed-advisors-llc-buys-regeneron-pharmaceuticals-inc-amicus-therapeutics-inc-loxo-oncology-inc-sells-incyte-corp-aetna-inc-biogen-inc Mar 12, 2018 - Orbimed Advisors Llc Buys Regeneron Pharmaceuticals Inc, Amicus Therapeutics Inc, Loxo Oncology Inc, Sells Incyte Corp, Aetna Inc, Biogen Inc, Stocks: REGN,LOXO,NVRO,ASMB,DCPH,EVHC,FOLD,RYTM,SCPH,DVA,A, release date:Mar 12, 2018
Orbimed Advisors Llc Buys Regeneron Pharmaceuticals Inc, Amicus Therapeutics Inc, Loxo Oncology ... http://www.gurufocus.com/news/649868/orbimed-advisors-llc-buys-regeneron-pharmaceuticals-inc-amicus-therapeutics-inc-loxo-oncology-inc-sells-incyte-corp-aetna-inc-biogen-inc Mar 06, 2018 - Orbimed Advisors Llc Buys Regeneron Pharmaceuticals Inc, Amicus Therapeutics Inc, Loxo Oncology Inc, Sells Incyte Corp, Aetna Inc, Biogen Inc, Stocks: REGN,LOXO,NVRO,ASMB,DCPH,EVHC,FOLD,RYTM,SCPH,DVA,A, release date:Mar 06, 2018
Orbimed Advisors Llc Buys Regeneron Pharmaceuticals Inc, Amicus Therapeutics Inc, Loxo Oncology ... http://www.gurufocus.com/news/645796/orbimed-advisors-llc-buys-regeneron-pharmaceuticals-inc-amicus-therapeutics-inc-loxo-oncology-inc-sells-incyte-corp-aetna-inc-biogen-inc Feb 23, 2018 - Orbimed Advisors Llc Buys Regeneron Pharmaceuticals Inc, Amicus Therapeutics Inc, Loxo Oncology Inc, Sells Incyte Corp, Aetna Inc, Biogen Inc, Stocks: REGN,LOXO,NVRO,ASMB,DCPH,EVHC,FOLD,RYTM,SCPH,DVA,A, release date:Feb 23, 2018
Healthcare: The 'Week That Was' Was Good https://seekingalpha.com/article/4138062-healthcare-week-was-good?source=feed_all_articles Jan 17, 2018 - Last month, I  explained my rationale for expecting favorable performance from healthcare stocks in January. In biopharmaceuticals, I highlighted Juno Therapeutics, bluebird bio, Madrigal, Arbutus, Co
Assembly Biosciences (ASMB) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow https://seekingalpha.com/article/4137311-assembly-biosciences-asmb-presents-36th-annual-j-p-morgan-healthcare-conference-slideshow?source=feed_sector_healthcare Jan 12, 2018 - The following slide deck was published by Assembly Biosciences, Inc. in conjunction with this event.
Your Daily Pharma Scoop: Ablynx Takeover Bid, Celgene Acquires Impact Biomedicines, Axovant Flops Again https://seekingalpha.com/article/4136211-daily-pharma-scoop-ablynx-takeover-bid-celgene-acquires-impact-biomedicines-axovant-flops?source=feed_sector_healthcare Jan 09, 2018 - Ablynx has received a $3.1 billion hostile takeover offer from Novo Nordisk.Celgene announced the acquisition of privately held Impact Biomedicines.Axovant announced another failed trial, pushing shar
ASMB: B. Riley FBR, Inc. starts at Neutral http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=UD20180105084539 Jan 05, 2018 - B. Riley FBR, Inc. issues rating change for ASMB
Medical Stocks: Investing For 2018 https://seekingalpha.com/article/4128929-medical-stocks-investing-2018?source=feed_all_articles Dec 01, 2017 - 2017 has turned out to be a favorable year for medical stock investing, especially in biopharma, devices, diagnostics and HMOs.In 2018, I expect there to be more balance between upside and downside, d

Pages: 123

<Page 2